Cardiovascular Events and Intensity of Treatment in Polycythemia Vera
2012 · New England Journal of Medicine · 791 citations
https://doi.org/10.1056/nejmoa1208500
M
Marco Ruggeri
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
221
Papers
14.7K
Citations
55
h-index
108
i10-index
Marco Ruggeri is an academic researcher from International Breast Cancer Study Group. The author has contributed to research in topics: Myeloproliferative Neoplasms: Diagnosis and Treatment & Eosinophilic Disorders and Syndromes & Kruppel-like factors research. The author has an h-index of 55, co-authored 188 publications.
ORCID: 0000-0003-1557-0957Papers by this author
worksPractice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia
2015 · Blood Cancer Journal · 261 citations
https://doi.org/10.1038/bcj.2015.94
Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients
2016 · Blood Cancer Journal · 98 citations
https://doi.org/10.1038/bcj.2016.103
Generation of mesenchymal stromal cells from cord blood: evaluation of in vitro quality parameters prior to clinical use
2017 · Stem Cell Research & Therapy · 60 citations
https://doi.org/10.1186/s13287-016-0465-2
Long-term safety and efficacy of givinostat in polycythemia vera: 4-year mean follow up of three phase 1/2 studies and a compassionate use program
2021 · Blood Cancer Journal · 42 citations
https://doi.org/10.1038/s41408-021-00445-z
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting
2018 · Blood Cancer Journal · 38 citations
https://doi.org/10.1038/s41408-018-0078-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat